Clinical trial · Observational
Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test
Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes for the Early Diagnosis and Screening of Gastric Cancer
NCT06943768CI-TRIAL-00091292not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a multicenter, cross-sectional study. It is based on fecal methylation site detection, H. pylori susceptibility testing of fecal samples, and a combination of the two, compared with the "gold standard" imaging tests, CT, gastroscopy and/or pathology, for gastric cancer, benign diseases such as gastritis, and health check-ups.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric (Stomach) Cancer | Childhood Gastric Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| fecal methylation site-based testing and fecal Helicobacter pylori gastric cancer susceptibility gene-based testing | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Sensitivity and specificity
- timeFrame
- Baseline
- description
- Sensitivity and specificity of fecal DNA methylation detection and Helicobacter pylori gastric cancer susceptibility genes based on their application for early diagnosis and screening of gastric cancer.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥ 18 years old, male or female not limited. * Within 90 days, the gastroscopy and/or pathological results confirm the absence of gastric cancer. * Patients must be able to fully understand the informed consent form and be able to personally sign it. Exclusion Criteria: * Severe cardiac, hepatic, or renal insufficiency, or psychiatric disorders. * A previous history of malignant tumors of the upper gastrointestinal tract. * Women during pregnancy. * Those with undefined pathology. * Those with unsatisfactory sample retention (e.g., too small a sample size)
References
Publications (0)
Data not yet available
No reference posted for this study.